Faa'iidooyinka saliidda Emu

Daraasadu ma taageertaa sheegashada caafimaadka?

Saliida Emu waa badeecad dabiici ah oo laga sameeyay dufanka la kariyey ee emu (shimbir weyn oo shimbir ah oo Australia ah). Noocyada antioxidants iyo dufanka aan laf dhabarta lahayn (oo ay ku jiraan omega-3 fatty acids), saliidda emu ayaa muddo dheer loo adeegsaday dhaqan aboriginal ah si loo daaweeyo xaaladaha maqaarka.

Nidaamkana waxaa loo qoondeeyey alaabooyinka anti-aging iyo anti-inflammatory, saliidda emu ayaa la sheegay in ay kor u qaadayso bogsashada dhaawacyada iyo daaweynta xaaladaha maqaarka sida faraha badan sida finanka, cambaarta , psoriasis, rosacea, iyo finanka.

Marka loo isticmaalo daryeelka timaha, saliidda emu waxaa la yiraahdaa kordhinta buuxda, ku dar dhalaal, adoo tirtiraya kala-goynta, iyo xakamaynta qashinka .

Faa'iidooyinka Caafimaadka ee Lagu Sameeyay

Marka laga reebo faa'iidadiisa maqaarka iyo timaha, saliidda emu waxaa la rumeeyaa qaar si loo daaweeyo xaalado caafimaad oo kale, oo ay ku jiraan kuwa la xiriira habka difaaca jirka . Iyaga ka mid ah:

Inkasta oo shirkadaha qaarkood ay si dhaqso ah u dardar geliyaan sheegashooyinkan, waxaa jira caddayn yar oo muujinaysa in saliidda emu ay hagaajin karto maqaarka qofka ama timaha, inta badan daaweyn xaalad caafimaad oo guud ama mid joogto ah. Caddaynta intooda badani waa anecdotal marka ugu fiican.

Iyadoo la sheegay, waxaa jiray dhowr daraasadood oo yar yar oo baaraya faa'iidooyinka saliidda emu ee daaweynta xaaladaha maqaarka caadiga ah iyo aan caadi ahayn. Halkan waxa ah waxa ay ka heleen:

Emu Oil ee Kiniiniga Kaansarka

Sida laga soo xigtay daraasad lagu daabacay Wargeyska Ingiriiska ee Nafaqada 2010, qaadashada saliida emu waxay ka caawin kartaa daweynta xaalad aan fiicnayn, xaalad kansar loo yaqaanno macaanka .

Mucositis waxaa caadi ahaan dadka khibrad u leh daaweynta kiimikada, waxaana lagu gartaa caabuqa xuubka xuubka ee mareenka dheefshiidka,

Daraasadan oo lagu sameeyay mammuucda sheybaarka, waxay ogaatay in saliida emu hoos u dhigtay xuubka mindhicirka ee xayawaanka ku dhaca daawooyinka kemotherabi. Inkastoo ay cadahay, ma cadda in haddii saliideedu ay faa'iido u tahay bini-aadanka.

Intaa waxaa dheer, in aan weli la xaqiijin sida ay u nabdoon tahay in saliiddu ay u isticmaasho.

Daraasad la mid ah waxay eegtay isticmaalka saliidda emu ee daaweynta dermatitis dadka ku jira daaweynta shucaaca. Sida laga soo xigtay cilmibaarista, daabacday bishii July 2015-ka ee daabacaadda Caalamiga ah ee Radiological Oncology, Biology, iyo Physics , dadka isticmaala codsiga maaddada saliidda emu ama saliida cambareynta inta lagu jiro daweynta iyo lix toddobaad kadib markii ay soo mareen xaalad jireed. Kuwa isticmaala saliida emu, si kastaba ha ahaatee, waxay yareeyeen dhacdooyinka maqaarka sunta marka loo eego kuwa isticmaala saliida cambariga.

Emu Oil si loo daaweeyo Xaaladaha Maqaarka ee caadiga ah

Kooxaha kale ee cilmi-baarista waxay sahamiyeen isticmaalka saliidda emu ee lagu daweeyo dhaawacyada maqaarka ee caadiga ah, sida barar iyo gubasho.

Mid ka mid ah daraasaddan, oo la sameeyay sannadkii 2016, ayaa baadhay saamaynta saliidda emu ku jirta naaska naaska nuujinaysa. Waxa ay ka heleen waxay ku jireen codsiga maalin kasta ee kiriimka emu-saliida ku saleysan ee haweenka naas-nuujinaya waxay si weyn u horumariyaan fuuq-celinta. (Fuuqbaxa maqaarka ayaa muhiim u ah ka hortagga dhibaatada maqaarka maqaarka inta lagu jiro naas nuujinta.) Si kastaba ha ahaatee, ma jirin wax qiimeyn ah oo ku saabsan nabadgelyada saliidda emu ee ilmaha naas-nuujinaya.

Cilmi-baarayaasha kale ayaa ujeedadoodu tahay in lagu qiimeeyo in saliida emu ay kor u qaadi karto bogsashada boogta.

Daraasadda xayawaanka ku salaysan ee lagu daabacay wargayska Dermatology Research and Practice ayaa lagu soo gabagabeeyay in isticmaalka saliidda emu si loo daweeyo gubashadu ay saameyn xun, hoos u dhigtay bogsashada iyo sii kordhinta caabuqa marka la barbar dhigo inaan wax daawo ah lahayn.

Maxaa Tani Usoo Sheegaya

Iyada oo ku saleysan cilmi-baarista, waxaa jira caddayn yar oo lagu taageerayo mid ka mid ah sheegashada caafimaadka ee la xidhiidha saliidda emu. Xaqiiqdii, Maamulka Cuntada iyo Dawooyinka ee Mareykanka ayaa saldhig u ah saliid emu ah oo lagu magacaabo "How to Spot a Health Fraud" oo uga digtay macaamiisha in ay "ka shakiyaan alaabooyinka dalbanaya in lagu daaweeyo cudurro badan oo aan xidhiidh la lahayn."

Guud ahaan, siyaabaha sida saliidda emu uma baahna inay maraan tijaabada adag ee daawooyinka dawooyinka.

Looma xakamaynayo si isku mid ah, iyo saameynta ay ku leeyihiin dadka khaaska ah (oo ay ku jiraan carruurta, haweenka uurka leh iyo dadka leh nidaamyada difaaca jirka ee la xakameynayo) ayaa sida caadiga ah lagu baaray ama gabi ahaanba la iska indho tiray.

Haddii aad ka fekereyso badeeco sida saliidda emu, marwalba kala hadal bixiyaha daryeelkaaga koowaad. Is-daweynta xaalad caafimaad iyo iska ilaalinta daryeelka caadiga ah waxay keeni kartaa cawaaqib xumo iyo mararka qaarkood aan dib loo noqon karin.

> Ilo:

> Afshar, M .; Ghaderi, R .; Zardaw, M. et al. "Saamaynta saliida Emu Saliida ah ee Boogaha Gubashada ee Maqaarka Balb / c Mice." Imtixaanka Dermatol ee Hawlgabka. 2016; 2016: 6419216. DOI: 10.1155 / 2016/6419216.

> Lindsey, R .; Geier, M .; Yasbeck, Y. et al. "Saliida dabiiciga ah ee loo yaqaan 'emu' ayaa hoos u dhigta bararka sambabada waxayna bedeshaa xaddiga xaddiga mindhicirka yar ee qaabka jaalaha ee xuubka. Brit J Nutrit. 2010; 104 (4): 513-9. DOI: 10.1017 / S000711451000084X.

> Rollmann, D .; Novotny, P .; Petersen, I. et al. "Daraasad laba-ilbiriqsi ah, Daraasad tijaabo ah oo la xakamaynayo ee Ultra Emu Oil Versus Placebo ee Hawl-galka ah ee Ka-hortagga Jirka Dheecaanka." 2015; 92 (3): 650-8. DOI: 10.1016.jrobp.2015.02.028

> Maamulka Cuntada iyo Dawooyinka Mareykanka. "Sida loo soo bandhigo khayaanada caafimaadka." Silver Spring, Maryland; la cusboonaysiiyay Maajo 5, 2016.

> Zanardo, V .; Giarrizzo, D .; Maiolo, L. et al. "Waxtarka Nidaamka Dhiigga ee Saliida Emu Shidnaanta Cudurka Maqaarka ee Haweenka Naasnuujinaya." J Evid Ku-saleysan Dhamaystiran Beddelka Med . 2016; 21 (1): 10-3. DOI: 10.1177 / 2156587215588653.